DR. LAYTH AL ATTAR

M.D.Real-Time Hydrated
Practice Location: WICHITA, KS 67214
NPI Number: 1023469269
LIFETIME INDUSTRY VALUE
$20,292
2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. AL ATTAR is a verified Internal Medicine practitioner based in WICHITA, KS.

Between 2021 and 2024, Dr. AL ATTAR had an overall industry promotional and research financial footprint of $20,292 as recorded in the federal CMS Open Payments database.

  • $20,292 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
  • $0 was allocated to sponsored clinical trials and medical research activities.

Dr. AL ATTAR's primary funding source is TRAVERE THERAPEUTICS, which accounts for $9,088 (representing 44.8% of overall industry footprint).

Data coverage: 2021 – 2024  ·  Source: CMS Open Payments  ·  CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments
Research Funding
$10,942$5,471$0$1,1012021$2,3772022$5,8712023$10,9422024

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

TRAVERE THERAPEUTICS
Rank 1
$9,088
44.8%
HORIZON THERAPEUTICS PLC
Rank 2
$4,076
20.1%
ASTRAZENECA PHARMACEUTICALS
Rank 3
$1,238
6.1%

General payments include consulting honoraria, promotional speaking fees, meals, travel, educational materials, and entertainment offsets.

PROMOTIONAL COUNT
Active
ESTIMATED COMPLIANCE RISK
Audit Trigger

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:
2024
2024
2023
2022
2021
Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.